The spleen is an important organ associated with various immune functions.[@b1-asm-5-351] There is a growing body of evidence that people without a spleen are particularly susceptible to various overwhelming infections including pneumonia, which carries a high mortality rate.[@b2-asm-5-351]--[@b6-asm-5-351]

Pneumonia is one of the most common infectious diseases in Taiwan. It ranked as the third leading cause of death in Taiwan in 2016.[@b7-asm-5-351] In addition to its high mortality, care for patients with pneumonia is relatively costlier, which has an impact on the global health service budget in Taiwan.[@b8-asm-5-351]

Although the association between splenectomy and pneumonia has been previously studied, there has been no formal study based on national claims data that focuses on Taiwan. Therefore, we conducted a retrospective population-based cohort study using claims data of the Taiwan National Health Insurance Program to investigate the association between splenectomy and pneumonia.

PATIENTS AND METHODS
====================

The Taiwan National Health Insurance Program has covered 99% of the Taiwan population since 1995.[@b9-asm-5-351] The claims data provide researchers with anonymous identification numbers associated with relevant claim information, including sex, date of birth, utilization of medical services, and prescriptions. The details of the insurance program have been described in previous reports.[@b10-asm-5-351]--[@b14-asm-5-351] This study was approved by the Research Ethics Committee of China Medical University and Hospital in Taiwan (CMUH-104-REC2-115).

In this retrospective population-based cohort study, all subjects aged 20--84 who underwent splenectomy from 2000 to 2010 were regarded as the splenectomy group (International Classification of Diseases, Ninth Revision, Clinical Modification, ICD-9 procedure code 41.5). The date for undergoing splenectomy was defined as the index date. For each subject with splenectomy, approximately 4 subjects without splenectomy were randomly selected from the same database and assigned to the non-splenectomy group. Both splenectomy and non-splenectomy groups were matched for sex, age (within 5-year interval), comorbidities, and the year of index date. To diminish the possibility of bias, subjects with a pneumonia diagnosis (ICD-9 codes 480--486) within one month after undergoing splenectomy were excluded from the study ([Figure 1](#f1-asm-5-351){ref-type="fig"}).

The main outcome was a diagnosis of pneumonia based on hospital discharge registries during the follow-up period. Each subject was monitored from the index date until diagnosed with pneumonia, or until the end of 2011. Comorbidities potentially related to pneumonia were included as follows: alcohol-related disease, cancer, chronic kidney disease, chronic liver disease (including cirrhosis, hepatitis B, hepatitis C, and other chronic hepatitis), chronic obstructive pulmonary disease, and diabetes mellitus. All comorbidities in the study were diagnosed based on ICD-9 codes. The validity of these ICD-9 codes have been well discussed in previous studies.[@b15-asm-5-351]--[@b19-asm-5-351]

Differences in sex, age, and comorbidities between the splenectomy group and the non-splenectomy group were compared using the chi-square test for categorical variables and the *t* test for continuous variables. The incidence of pneumonia was measured as the number of pneumonia events identified during the follow-up period, divided by the total follow-up person-years for each group. The incidence rate ratio (IRR) with 95% confidence interval (CI) for the splenectomy to non-splenectomy group was measured using Poisson regression, stratified by sex and age. At first, all variables were included in a univariate model. Those found to be statistically significant in a univariate model were further included in a multivariate model. A multivariate Cox proportional hazards regression model was used to measure the hazard ratio (HR) and 95% CI for pneumonia associated with splenectomy and other comorbidities. All statistical analyses were performed by using SAS 9.2 (SAS Institute, Cary, North Carolina, USA). Two-tailed *P*\<.05 was considered statistically significant.

RESULTS
=======

There were 12 757 subjects with splenectomy and 51 019 subjects without splenectomy during the study period, with similar distributions of sex and age ([Table 1](#t1-asm-5-351){ref-type="table"}). Males constituted a higher proportion in both groups. The mean ages of the study subjects were not statistically different between the groups. The mean follow-up periods were 4.32 (3.43) years in the splenectomy group and 5.68 (3.33) years in the non-splenectomy group (*t* test, *P*\<.001). The proportions of alcohol-related disease, cancer, chronic kidney disease, chronic liver disease, chronic obstructive pulmonary disease, and diabetes mellitus were equally distributed in the splenectomy group and the non-splenectomy group (chi-square test, *P*\>.05 for all).

At the end of the cohort study, the overall incidence of pneumonia was 1.86-fold higher in the splenectomy group than in the non-splenectomy group (25.0 vs. 13.4 per 1000 person-years, 95% CI 1.78, 1.95) ([Table 2](#t2-asm-5-351){ref-type="table"}). The incidence of pneumonia, as stratified by sex and age, was higher in the splenectomy group than in the non-splenectomy group. The incidence of pneumonia increased with age in both groups, with the highest in the splenectomy group aged 65--84 years (64.8 per 1,000 person-years). The sub-analysis stratified by follow-up demonstrated that the incidence rate ratio of pneumonia between the splenectomy group and the non-splenectomy group was 2.07 (27.4 vs. 13.2 per 1000 person-years, 95% CI 1.98--2.17) in the first 5 years of follow-up. The incidence rate ratio of pneumonia was 1.35 (18.8 vs. 13.9 per 1000 person-years, 95% CI 1.25--1.46) even after 5 years. The Kaplan-Meier model demonstrates that the splenectomy group had a higher cumulative incidence of pneumonia than the non-splenectomy group (19.3% vs. 12.8% at the end of follow-up; *P*\< 0.001, [Figure 2](#f2-asm-5-351){ref-type="fig"}).

Only variables found to be statistically significant in a univariate model were further examined in a multivariate model. After multivariate analysis, the multivariate Cox proportional hazards regression model demonstrated that the adjusted HR for pneumonia was 2.2 for subjects with splenectomy (95% CI 2.07, 2.34), compared with subjects without splenectomy ([Table 3](#t3-asm-5-351){ref-type="table"}). In addition, male sex, alcohol-related disease, cancer, chronic kidney disease, chronic liver disease, chronic obstructive pulmonary disease, and diabetes mellitus were associated with pneumonia. Every one-year increase in age was associated with a 1.06-fold increased risk of pneumonia (95% CI 1.05, 1.06).

[Table 4](#t4-asm-5-351){ref-type="table"} shows the interaction effects on the risk of pneumonia between splenectomy and other comorbidities including alcohol-related disease, cancer, chronic kidney disease, chronic liver disease, chronic obstructive pulmonary disease, and diabetes mellitus. As a reference for subjects without splenectomy and without any comorbidity, the adjusted HR of pneumonia was 3.03 for subjects with splenectomy alone and without any comorbidity (95% CI 2.76, 3.33). The adjusted HR markedly increased to 5.28 for those with splenectomy and with any comorbidity (95% CI 4.82, 5.78).

DISCUSSION
==========

We found that the overall incidence of pneumonia was 1.86-fold higher in the splenectomy group than that in the non-splenectomy group. This finding suggests that approximately 12 additional cases of pneumonia would develop per 1000 patients with splenectomy annually. We also found that the incidence of pneumonia was higher in patients with splenectomy regardless of sex or age. The incidence of pneumonia in patients with splenectomy seemed higher than in patients with schizophrenia in Taiwan (25.0 vs. 11.4 per 1,000 person-years), [@b12-asm-5-351] but lower than in patients with chronic kidney disease in Taiwan (25.0 vs. 65.6 per 1,000 person-years). [@b13-asm-5-351] We noticed that patients aged 65--84 years in the splenectomy group had the highest incidence of pneumonia (64.8 per 1,000 person-years). The sub-analysis stratified by follow-up period demonstrated that the risk of pneumonia in the splenectomy group was significantly higher in the first 5 years of follow-up (incidence rate ratio 2.07, 95% CI 1.98--2.17). However, the risk of pneumonia still existed in the splenectomy group even after 5 years (incidence rate ratio 1.35, 95% CI 1.25--1.46).

After multivariate analysis, we noticed that splenectomy was associated with a 2.2-fold increased risk of pneumonia. Patients with splenectomy seemed to have a higher hazard ratio for pneumonia compared with patients with schizophrenia in Taiwan (adjusted HR 1.39).[@b12-asm-5-351] This finding suggests that patients with splenectomy are more likely to develop pneumonia than those with schizophrenia. Some patients could develop pneumonia early due to procedural complications of splenectomy. A subject with a pneumonia diagnosis in the first month was excluded since the diagnosis could be an early surgical complication rather than a splenectomy-related immunocompromised status.

In addition, the lack of a difference in the prevalence of comorbidities between the splenectomy group and the non-splenectomy group indicates that the increased HR was not confounded by comorbidities. That is, the increased risk of pneumonia in patients with splenectomy could not be completely attributable to the impact of comorbidities. In further analysis, even in the absence of any comorbidity, patients with splenectomy still had a higher risk of pneumonia (adjusted HR 3.03, [Table 4](#t4-asm-5-351){ref-type="table"}). This finding means that splenectomy has a unique role in the risk of developing pneumonia no matter whether comorbidity co-exists or not. The risk markedly increased for those with splenectomy and any comorbidity (adjusted HR 5.28, [Table 4](#t4-asm-5-351){ref-type="table"}). This finding suggests that there is an interaction effect on the risk of pneumonia between splenectomy and comorbidities. Although the association between splenectomy and blood borne infections has been acknowledged for many years,[@b1-asm-5-351] these findings are consistent with previous studies that patients with splenectomy are more susceptible to various overwhelming infections including pneumonia.[@b2-asm-5-351]--[@b6-asm-5-351],[@b10-asm-5-351],[@b12-asm-5-351],[@b19-asm-5-351]

Some limitations in the present study deserve discussion. First, pneumococcal vaccination significantly reduces the risk of pneumonia in patients with splenectomy, and therefore vaccination is recommended by many countries.[@b20-asm-5-351] However, vaccination for pneumococcal pneumonia and influenza was not universally performed in Taiwan from 2000 to 2010. We were unable investigate whether pneumococcal and influenza vaccination might decrease the risk of pneumonia among patients with splenectomy because vaccination records were incomplete. Second, some behavioral risk factors for pneumonia, such as alcohol consumption and cigarette smoking, were not recorded in the database. In our analysis, we used alcohol-related disease instead of alcohol consumption and chronic obstructive pulmonary disease in place of cigarette smoking. Third, *Streptococcus pneumoniae, Mycoplasma pneumoniae*, and *Chlamydia pneumoniae* are the most common causative pathogens of pneumonia in Taiwan, accounting for 45%--59% of pneumonia patients.[@b21-asm-5-351],[@b22-asm-5-351] ICD-9 codes do not differentiate if the pneumonia is caused by a viral, a bacterial or unspecified organisms. We could not investigate which pathogens were more likely to be found among patients with splenectomy. It would be of interest to distinguish the different pathogens causing pneumonia so as to optimize a vaccination program. Fourth, the diagnosis of pneumonia was based on the ICD-9 codes recorded in the hospital discharge registries. Though radiographs were not recorded. Also, we could not assess sensitivity/specificity of a single code for pneumonia, but in view of the high quality of medical practice in Taiwan, chest radiographs should have been performed during hospitalization among patients suspected of having pneumonia. Only after radiological confirmation is the diagnosis of pneumonia made. Thus, pneumonia based on the ICD-9 codes recorded in the hospital discharge registries is accurate. Last, a diagnosis based on the coding system also fails to distinguish between community-acquired and hospital-acquired pneumonia. Most of hospital-acquired pneumonia is caused by multidrug resistant bacteria, which may not be relevant with splenectomy. Whether splenectomy also increases the risk of hospital-acquired pneumonia is a question for future research.

A strength of our study is the use of high-quality claims data with a large sample size, which increases the statistical power. The results were fairly impressive. Though the matter of an increase in pneumonia in patients with splenectomy has been reported before, this study provides updated evidence for this country based on national claims data. We conclude that splenectomy increases the relative risk for developing pneumonia 2.2-fold in Taiwan. Five years after splenectomy, the risk persists. Even in the absence of any comorbidity, the risk remains high. Patients with splenectomy should receive preventive interventions for pneumonia such as vaccination.
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![Kaplan-Meier graph for incidence of pneumonia in splenectomy and non-splenectomy groups (19.3% vs. 12.8% at the end of follow-up; log-rank test, *P*\<.001).](asm-5-351f2){#f2-asm-5-351}

###### 

Baseline characteristics of the splenectomy and non-splenectomy groups.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                                                                                       Nonsplenectomy (n=51 019)\   Splenectomy (n=12 757)\   *P* value[\*](#tfn2-asm-5-351){ref-type="table-fn"}
                                                                                                 n (%)                        n (%)                     
  ---------------------------------------------------------------------------------------------- ---------------------------- ------------------------- -----------------------------------------------------
  **Sex**                                                                                                                                               **.99**

  Female                                                                                         19 873 (39.0)                4969 (39.0)               

  Male                                                                                           31146 (61.0)                 7788 (61.0)               

  **Age group (years)**                                                                                                                                 **.99**

  20--39                                                                                         13 328 (26.1)                3331 (26.1)               

  40--64                                                                                         23 907 (46.9)                5980 (46.9)               

  65--84                                                                                         13 784 (27.0)                3446 (27.0)               

  **Age (years), mean (standard deviation)**[†](#tfn3-asm-5-351){ref-type="table-fn"}            **52.0 (17.1)**              **52.3 (17.0)**           **.12**

  Follow-up period (years), mean (standard deviation)[†](#tfn3-asm-5-351){ref-type="table-fn"}   5.68 (3.33)                  4.32 (3.43)               \<.001

  **Baseline comorbidities**                                                                                                                            

  Alcohol-related disease                                                                        1784 (3.50)                  448 (3.51)                .93

  Cancer                                                                                         7612 (14.9)                  1905 (14.9)               .97

  Chronic kidney disease                                                                         943 (1.85)                   236 (1.85)                .99

  Chronic liver disease                                                                          7570 (14.8)                  1894 (14.9)               .98

  Chronic obstructive pulmonary disease                                                          1515 (2.97)                  379 (2.97)                .99

  Diabetes mellitus                                                                              7430 (14.6)                  1859 (14.6)               .98
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data are number (percentages) or mean (standard deviation).

Chi-square test, and

*t* test comparing subjects with and without splenectomy.

###### 

Incidence of pneumonia stratified by sex and age between the splenectomy and non-splenectomy groups.

  Variable                Non-splenectomy   Splenectomy   IRR[\#](#tfn5-asm-5-351){ref-type="table-fn"}   95% CI                                        
  ----------------------- ----------------- ------------- ----------------------------------------------- -------- ------- ------ ------- ------ ------ --------------
  All                     51019             3890          289864                                          13.4     12757   1380   55168   25.0   1.86   (1.78, 1.95)
  **Sex**                                                                                                                                               
  Female                  19873             1078          114942                                          9.38     4969    391    22075   17.7   1.89   (1.75, 2.04)
  Male                    31146             2812          174921                                          16.1     7788    989    33093   29.9   1.86   (1.76, 1.97)
  **Age group (years)**                                                                                                                                 
  20--39                  13328             242           83427                                           2.90     3331    176    19351   9.10   3.14   (2.86, 3.44)
  40--64                  23907             1234          137984                                          8.94     5980    543    25616   21.2   2.37   (2.22, 2.53)
  65--84                  13784             2414          68452                                           35.3     3446    661    10202   64.8   1.84   (1.70, 1.99)

Incidence: per 1000 person-years

Incident rate ratio non-splenectomy vs splenectomy adjusted for sex and age

###### 

Hazard ratio and 95% confidence interval for pneumonia associated with splenectomy and comorbidities.

  Variable                                  Crude   Adjusted[\#](#tfn6-asm-5-351){ref-type="table-fn"}          
  ----------------------------------------- ------- ---------------------------------------------------- ------ -------------
  Sex (male vs. female)                     1.70    1.60, 1.81                                           1.70   1.59, 1.80
  Age (per year)                            1.06    1.05, 1.06                                           1.06   1.05, 1.06)
  **Baseline comorbidities (yes vs. no)**                                                                       
  Splenectomy                               1.85    1.74, 1.97                                           2.20   2.07, 2.34
  Alcohol-related disease                   1.70    1.50, 1.92                                           2.58   2.27, 2.93
  Cancer                                    2.37    2.22, 2.53                                           1.72   1.61, 1.84
  Chronic kidney disease                    3.39    2.98, 3.86                                           2.40   2.10, 2.73
  Chronic liver disease                     1.46    1.36, 1.57                                           1.35   1.26, 1.46
  Chronic obstructive pulmonary disease     5.77    5.29, 6.29                                           2.36   2.16, 2.58
  Diabetes mellitus                         2.74    2.58, 2.91                                           1.76   1.65, 1.87

Variables found to be statistically significant in a univariable model (all were statistically significant) were further examined in a multivariable model. Adjusted for sex, age, alcohol-related disease, cancer, chronic kidney disease, chronic liver disease, chronic obstructive pulmonary disease, and diabetes mellitus

###### 

Cox proportional hazard regression analysis for risk of pneumonia stratified by splenectomy and comorbidities.

  Variable Splenectomy   Any comorbidity[\*](#tfn9-asm-5-351){ref-type="table-fn"}   Event (n)   Incidence[†](#tfn7-asm-5-351){ref-type="table-fn"}   Adjusted HR[\#](#tfn8-asm-5-351){ref-type="table-fn"} (95% CI)
  ---------------------- ----------------------------------------------------------- ----------- ---------------------------------------------------- ----------------------------------------------------------------
  No                     No                                                          1321        6.77                                                 (Reference)
  No                     Yes                                                         2569        27.1                                                 2.98 (2.78, 3.18)
  Yes                    No                                                          654         16.8                                                 3.03 (2.76, 3.33)
  Yes                    Yes                                                         726         44.5                                                 5.28 (4.82, 5.78)

Incidence: per 1000 person-years

Adjusted for sex and age

Comorbidities including alcohol-related disease, cancer, chronic kidney disease, chronic liver disease, chronic obstructive pulmonary disease, and diabetes mellitus
